Hansoh Pharmaceutical Group Future Growth
Future criteria checks 2/6
Hansoh Pharmaceutical Group is forecast to grow earnings and revenue by 2.7% and 6.9% per annum respectively. EPS is expected to grow by 2.3% per annum. Return on equity is forecast to be 12.4% in 3 years.
Key information
2.7%
Earnings growth rate
2.3%
EPS growth rate
Pharmaceuticals earnings growth | 21.6% |
Revenue growth rate | 6.9% |
Future return on equity | 12.4% |
Analyst coverage | Good |
Last updated | 18 Nov 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 13,866 | 4,433 | 4,384 | 4,225 | 20 |
12/31/2025 | 12,367 | 3,899 | 3,826 | 3,944 | 23 |
12/31/2024 | 12,056 | 4,149 | 3,679 | 3,372 | 23 |
6/30/2024 | 12,098 | 4,714 | 4,137 | 4,653 | N/A |
3/31/2024 | 11,101 | 3,996 | 3,446 | 3,885 | N/A |
12/31/2023 | 10,104 | 3,278 | 2,754 | 3,116 | N/A |
9/30/2023 | 9,782 | 2,926 | 2,292 | 2,615 | N/A |
6/30/2023 | 9,459 | 2,575 | 1,830 | 2,114 | N/A |
3/31/2023 | 9,421 | 2,579 | 2,140 | 2,427 | N/A |
12/31/2022 | 9,382 | 2,584 | 2,449 | 2,741 | N/A |
9/30/2022 | 9,675 | 2,652 | 2,646 | 3,004 | N/A |
6/30/2022 | 9,968 | 2,720 | 2,842 | 3,267 | N/A |
3/31/2022 | 9,952 | 2,717 | 2,472 | 2,922 | N/A |
12/31/2021 | 9,935 | 2,713 | 2,102 | 2,577 | N/A |
9/30/2021 | 9,524 | 2,675 | 1,415 | 2,345 | N/A |
6/30/2021 | 9,112 | 2,638 | 729 | 2,113 | N/A |
3/31/2021 | 8,901 | 2,603 | 840 | 2,252 | N/A |
12/31/2020 | 8,690 | 2,569 | 951 | 2,390 | N/A |
9/30/2020 | 8,377 | 2,526 | 1,775 | 2,802 | N/A |
6/30/2020 | 8,063 | 2,483 | 2,600 | 3,213 | N/A |
3/31/2020 | 8,373 | 2,520 | 2,666 | 3,271 | N/A |
12/31/2019 | 8,683 | 2,557 | 2,732 | 3,330 | N/A |
9/30/2019 | 8,615 | 2,357 | 2,529 | 3,092 | N/A |
6/30/2019 | 8,548 | 2,157 | 2,325 | 2,854 | N/A |
3/31/2019 | 8,135 | 2,030 | 2,008 | 2,463 | N/A |
12/31/2018 | 7,722 | 1,903 | 1,690 | 2,072 | N/A |
12/31/2017 | 6,186 | 1,595 | N/A | 1,402 | N/A |
12/31/2016 | 5,433 | 1,476 | N/A | 1,247 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 3KY's forecast earnings growth (2.7% per year) is above the savings rate (1%).
Earnings vs Market: 3KY's earnings (2.7% per year) are forecast to grow slower than the German market (20.8% per year).
High Growth Earnings: 3KY's earnings are forecast to grow, but not significantly.
Revenue vs Market: 3KY's revenue (6.9% per year) is forecast to grow faster than the German market (5.6% per year).
High Growth Revenue: 3KY's revenue (6.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 3KY's Return on Equity is forecast to be low in 3 years time (12.4%).